JP2022517842A5 - - Google Patents
Info
- Publication number
- JP2022517842A5 JP2022517842A5 JP2021542307A JP2021542307A JP2022517842A5 JP 2022517842 A5 JP2022517842 A5 JP 2022517842A5 JP 2021542307 A JP2021542307 A JP 2021542307A JP 2021542307 A JP2021542307 A JP 2021542307A JP 2022517842 A5 JP2022517842 A5 JP 2022517842A5
- Authority
- JP
- Japan
- Prior art keywords
- transformation
- approximately
- diffraction pattern
- manufacturing
- cukα
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024074242A JP2024099797A (ja) | 2019-01-23 | 2024-05-01 | 7-シクロペンチル-2-(5-ピペラジン-1-イル-ピリジン-2-イルアミノ)-7H-ピロロ[2,3-d]ピリミジン-6-カルボン酸ジメチルアミドのコハク酸塩の新規な結晶形態 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962795799P | 2019-01-23 | 2019-01-23 | |
| US62/795,799 | 2019-01-23 | ||
| PCT/IB2020/050544 WO2020152629A1 (en) | 2019-01-23 | 2020-01-23 | New crystalline forms of a succinate salt of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine -6-carboxylic acid dimethylamide |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024074242A Division JP2024099797A (ja) | 2019-01-23 | 2024-05-01 | 7-シクロペンチル-2-(5-ピペラジン-1-イル-ピリジン-2-イルアミノ)-7H-ピロロ[2,3-d]ピリミジン-6-カルボン酸ジメチルアミドのコハク酸塩の新規な結晶形態 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022517842A JP2022517842A (ja) | 2022-03-10 |
| JP2022517842A5 true JP2022517842A5 (cg-RX-API-DMAC10.html) | 2023-02-01 |
Family
ID=69467591
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021542307A Pending JP2022517842A (ja) | 2019-01-23 | 2020-01-23 | 7-シクロペンチル-2-(5-ピペラジン-1-イル-ピリジン-2-イルアミノ)-7H-ピロロ[2,3-d]ピリミジン-6-カルボン酸ジメチルアミドのコハク酸塩の新規な結晶形態 |
| JP2024074242A Pending JP2024099797A (ja) | 2019-01-23 | 2024-05-01 | 7-シクロペンチル-2-(5-ピペラジン-1-イル-ピリジン-2-イルアミノ)-7H-ピロロ[2,3-d]ピリミジン-6-カルボン酸ジメチルアミドのコハク酸塩の新規な結晶形態 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024074242A Pending JP2024099797A (ja) | 2019-01-23 | 2024-05-01 | 7-シクロペンチル-2-(5-ピペラジン-1-イル-ピリジン-2-イルアミノ)-7H-ピロロ[2,3-d]ピリミジン-6-カルボン酸ジメチルアミドのコハク酸塩の新規な結晶形態 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US12390468B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3914353A1 (cg-RX-API-DMAC10.html) |
| JP (2) | JP2022517842A (cg-RX-API-DMAC10.html) |
| CN (1) | CN113316471A (cg-RX-API-DMAC10.html) |
| AU (2) | AU2020211071A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3124015A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL284510B2 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2020152629A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020002123A (es) | 2017-08-25 | 2020-09-18 | Sicor Soc It Corticosteroidi S R L | Sales de ribociclib y formas en estado sólido de las mismas. |
| WO2020152629A1 (en) | 2019-01-23 | 2020-07-30 | Novartis Ag | New crystalline forms of a succinate salt of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine -6-carboxylic acid dimethylamide |
| EP4626890A1 (en) | 2022-12-01 | 2025-10-08 | KRKA, d.d., Novo mesto | Ribociclib salts and formulations thereof |
| EP4762058A1 (en) * | 2023-08-18 | 2026-06-24 | Alembic Pharmaceuticals Limited | Polymorph of ribociclib salt |
| WO2025144118A1 (en) * | 2023-12-27 | 2025-07-03 | Deva Holding | Novel polymorph of ribociclib dihydrochloride dihydrate and method of preparation |
| US20250319032A1 (en) | 2024-04-15 | 2025-10-16 | Novartis Ag | Pharmaceutical compositions of ribociclib |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI992711A1 (it) | 1999-12-27 | 2001-06-27 | Novartis Ag | Composti organici |
| EA012926B1 (ru) | 2001-12-20 | 2010-02-26 | Оси Фармасьютикалз, Инк. | Пирролопиримидиновые соединения, относящиеся к a-селективным антагонистам, их синтез и применение |
| SG146624A1 (en) | 2003-09-11 | 2008-10-30 | Kemia Inc | Cytokine inhibitors |
| JP2008506761A (ja) | 2004-07-22 | 2008-03-06 | アステックス、セラピューティックス、リミテッド | プロテインキナーゼ阻害剤としてのチアゾールおよびイソチアゾール誘導体 |
| BRPI0612997A2 (pt) | 2005-07-22 | 2010-12-14 | Qualcomm Incorporated | dispositivos mems e respectivos mÉtodos de fabrico |
| WO2007075783A2 (en) | 2005-12-22 | 2007-07-05 | Wyeth | Substituted isoquinoline-1,3(2h,4h)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2h)-isoquinolones and use thereof as kinase inhibitor |
| TWI398252B (zh) | 2006-05-26 | 2013-06-11 | 諾華公司 | 吡咯并嘧啶化合物及其用途 |
| AU2009284098B2 (en) | 2008-08-22 | 2012-03-29 | Astex Therapeutics Ltd. | Pyrrolopyrimidine compounds as CDK inhibitors |
| AR081331A1 (es) | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
| AR083797A1 (es) | 2010-11-10 | 2013-03-20 | Novartis Ag | Succinato de dimetil-amida del acido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]pirimidin-6-carboxilico, proceso para prepararla, intermediarios de dicha sintesis y proceso de preparacion de los mismos |
| TW201636330A (zh) | 2011-05-24 | 2016-10-16 | 拜耳知識產權公司 | 含有硫醯亞胺基團之4-芳基-n-苯基-1,3,5-三氮雜苯-2-胺 |
| ES2910444T3 (es) | 2012-02-24 | 2022-05-12 | Nokia Technologies Oy | Método y aparato para establecer una conexión con una red de acceso basándose en información de interfuncionamiento de red de acceso |
| CN105111215B (zh) * | 2014-12-12 | 2019-06-18 | 苏州晶云药物科技股份有限公司 | 一种周期蛋白依赖性激酶抑制剂的晶型及其制备方法 |
| US10138250B2 (en) | 2014-12-12 | 2018-11-27 | Crystal Pharmatech Co., Ltd. | Salt of pyrrolo[2,3-D]pyrimidine compound and novel polymorph of salt |
| WO2016091221A1 (zh) | 2014-12-12 | 2016-06-16 | 苏州晶云药物科技有限公司 | 吡咯并[2,3-d]嘧啶化合物的盐及盐的新晶型 |
| US10323035B2 (en) | 2015-04-01 | 2019-06-18 | Crystal Pharmatech Co., Ltd. | Co-crystal of a CDK inhibitor and an MEK inhibitor and process of preparation thereof |
| MX2020002123A (es) | 2017-08-25 | 2020-09-18 | Sicor Soc It Corticosteroidi S R L | Sales de ribociclib y formas en estado sólido de las mismas. |
| WO2019111160A1 (en) | 2017-12-04 | 2019-06-13 | Sun Pharmaceutical Industries Limited | Crystalline forms of ribociclib succinate |
| WO2019123364A1 (en) | 2017-12-22 | 2019-06-27 | Shilpa Medicare Limited | Novel polymorphs of ribociclib mono succinate |
| WO2019142206A1 (en) | 2018-01-20 | 2019-07-25 | Natco Pharma Limited | An improved process for the preparation of ribociclib succinate and its novel crystalline forms thereof |
| TWI675662B (zh) * | 2018-05-17 | 2019-11-01 | 中化合成生技股份有限公司 | 瑞博西尼琥珀酸鹽(Ribociclib succinate salt)晶型B、C及D與其衍生物,以及其等之製造方法與藥物組合物 |
| WO2020152629A1 (en) | 2019-01-23 | 2020-07-30 | Novartis Ag | New crystalline forms of a succinate salt of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine -6-carboxylic acid dimethylamide |
-
2020
- 2020-01-23 WO PCT/IB2020/050544 patent/WO2020152629A1/en not_active Ceased
- 2020-01-23 CA CA3124015A patent/CA3124015A1/en active Pending
- 2020-01-23 EP EP20703523.9A patent/EP3914353A1/en active Pending
- 2020-01-23 AU AU2020211071A patent/AU2020211071A1/en not_active Abandoned
- 2020-01-23 IL IL284510A patent/IL284510B2/en unknown
- 2020-01-23 JP JP2021542307A patent/JP2022517842A/ja active Pending
- 2020-01-23 US US17/424,690 patent/US12390468B2/en active Active
- 2020-01-23 CN CN202080009222.3A patent/CN113316471A/zh active Pending
-
2023
- 2023-02-10 AU AU2023200724A patent/AU2023200724B2/en active Active
-
2024
- 2024-05-01 JP JP2024074242A patent/JP2024099797A/ja active Pending
- 2024-11-26 US US18/960,021 patent/US20250281492A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI670270B (zh) | 包含jak抑制劑之醫藥組合物 | |
| JP5684192B2 (ja) | トリアゾロ[4,5−d]ピリミジン化合物の新規な結晶形及び非晶形 | |
| US20090247532A1 (en) | Crystalline polymorph of sitagliptin phosphate and its preparation | |
| JP2022530441A (ja) | 7h-ピロロ[2,3-d]ピリミジンjak-阻害剤 | |
| AU2023200724B2 (en) | New crystalline forms of a succinate salt of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine -6-carboxylic acid dimethylamide | |
| TW200827356A (en) | Salts and crystall forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile | |
| CN101253176B (zh) | 哒嗪并[4,5-b]吲哚衍生物的新晶形 | |
| CN104010636A (zh) | 三环化合物、包含它们的组合物及其用途 | |
| JP2026041824A (ja) | テガビビントの結晶形態、調製方法、及びその使用 | |
| JP7168447B2 (ja) | ビラスチンの結晶形態及びそれらの調製方法 | |
| CN104098570A (zh) | 替卡格雷晶型及其制备方法和用途 | |
| CN114057823B (zh) | 白桦脂酸衍生物,其制备方法、药物组合物和应用 | |
| JP2004504390A (ja) | (r)−n−[5−メチル−8−(4−メチルピペラジン−1−イル)−1,2,3,4−テトラヒドロ−2−ナフチル]−4−モルホリノベンズアミドの新規な形態 | |
| TWI751220B (zh) | 一種GnRH受體拮抗劑的多晶型及其製備方法 | |
| EP1844017A1 (en) | An amorphous and three crystalline forms of rimonabant hydrochloride | |
| WO2012055163A1 (zh) | 来曲唑i型结晶及其制备方法 | |
| RU2021124673A (ru) | Новые кристаллические формы сукцинатной соли диметиламида 7-циклопентил-2-(5-пиперазин-1-илпиридин-2-иламино)-7h-пирроло[2,3-d]пиримидин-6-карбоновой кислоты | |
| TWI902254B (zh) | 化合物8-氯-3-戊基-3,7-二氫-1h-嘌呤-2,6-二酮的晶型及其製備方法 | |
| JP2022532186A (ja) | 非晶質のpi3k阻害剤及びこれを含有する医薬組成物 | |
| WO2024179463A1 (zh) | 化合物8-氯-3-戊基-3,7-二氢-1h-嘌呤-2,6-二酮的晶型及其制备方法 | |
| WO2025203051A1 (en) | Ribociclib succinate form c and process thereof | |
| JP2001518088A (ja) | 抗不整脈薬として有用なニトロベンズアミド | |
| JP2024544772A (ja) | Ret阻害剤であるセルペルカチニブの結晶形態aの調製方法 | |
| TWI330082B (en) | Crystalline form of triazolo(4,5-d)pyrimidine compound and method of preparing the same | |
| WO2025045072A1 (zh) | 一种酞嗪酮类化合物及其制备方法、药物组合物及用途 |